Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.08
-6.9%
$0.08
$0.06
$0.29
$870K0.57,689 shs152 shs
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
$7.23
-10.4%
$4.07
$2.90
$168.00
$5.96M-0.18534,047 shs151,404 shs
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$0.11
-4.3%
$0.14
$0.06
$6.00
$2.32M0.43582,300 shs243,509 shs
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
$5.78
+1.4%
$0.00
$2.20
$47.70
$5.72M0.495.40 million shs1.49 million shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dynatronics Co. stock logo
DYNT
Dynatronics
-6.93%+5.13%-5.21%-4.66%-56.92%
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
-10.41%-18.21%+113.27%+97.00%-99.91%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
-4.26%-12.35%-21.43%+1.85%-98.10%
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
+1.40%+143.88%+577,999,900.00%+577,999,900.00%+577,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/AN/AN/AN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
3.176 of 5 stars
3.55.00.00.03.80.00.6
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
2.3015 of 5 stars
3.05.00.00.00.00.00.0
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00
N/AN/AN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
3.00
Buy$50.00591.56% Upside
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
2.00
Hold$5.004,445.45% Upside
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest DYNT, TTOO, NDRA, and XAGE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/21/2025
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$75.00 ➝ $50.00
(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Dynatronics Co. stock logo
DYNT
Dynatronics
$33.60M0.03N/AN/A$0.57 per share0.14
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/AN/AN/AN/A$4.77 per shareN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$7.68M0.30N/AN/A($6.91) per share-0.02
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
$50K115.60N/AN/A($6.77) per share-0.85
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Dynatronics Co. stock logo
DYNT
Dynatronics
-$2.70M-$0.78N/AN/A-8.35%-41.81%-9.56%9/22/2025 (Estimated)
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
-$11.51M-$172.04N/AN/AN/AN/A-140.96%-106.14%8/13/2025 (Estimated)
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
-$50.08MN/A0.00N/A-563.16%N/A-174.06%7/28/2025 (Estimated)
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
-$10.37MN/A0.00N/A-1,535.11%N/A-280.07%N/A

Latest DYNT, TTOO, NDRA, and XAGE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
-$2.27N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/AN/AN/AN/AN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
N/AN/AN/AN/AN/A
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Dynatronics Co. stock logo
DYNT
Dynatronics
0.25
1.21
0.60
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/A
3.85
3.85
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
N/A
0.40
0.24
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
N/A
0.42
0.21

Institutional Ownership

CompanyInstitutional Ownership
Dynatronics Co. stock logo
DYNT
Dynatronics
4.18%
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
1.19%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
23.18%
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
24.22%

Insider Ownership

CompanyInsider Ownership
Dynatronics Co. stock logo
DYNT
Dynatronics
7.98%
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
0.04%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
0.03%
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
29.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Dynatronics Co. stock logo
DYNT
Dynatronics
20010.62 million8.11 millionNot Optionable
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
20740,000738,000Not Optionable
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
18021.04 million21.04 millionOptionable
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
141.00 million713,000N/A

New MarketBeat Followers Over Time

Media Sentiment Over Time

Dynatronics stock logo

Dynatronics NASDAQ:DYNT

$0.08 -0.01 (-6.93%)
As of 07/16/2025 09:44 AM Eastern

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

ENDRA Life Sciences stock logo

ENDRA Life Sciences NASDAQ:NDRA

$7.23 -0.84 (-10.41%)
Closing price 07/16/2025 04:00 PM Eastern
Extended Trading
$7.25 +0.02 (+0.28%)
As of 06:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

T2 Biosystems stock logo

T2 Biosystems NASDAQ:TTOO

$0.11 0.00 (-4.26%)
As of 07/16/2025 03:55 PM Eastern

T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Longevity Health stock logo

Longevity Health NASDAQ:XAGE

$5.78 +0.08 (+1.40%)
As of 07/16/2025 04:00 PM Eastern

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.